Palvella Therapeutics, Inc. (PVLA) vs Sarepta Therapeutics, Inc. (SRPT)
- Palvella Therapeutics, Inc. PVLA 120.30 −5.53%
- Sarepta Therapeutics, Inc. SRPT 17.06 −4.10%
Palvella Therapeutics, Inc. and Sarepta Therapeutics, Inc. are both Biotechnology companies. Palvella Therapeutics, Inc. and Sarepta Therapeutics, Inc. are of similar size ($1.9B and $1.8B). Palvella Therapeutics, Inc. grew revenue faster over the last twelve months: 146.7% against −20.4%. Palvella Therapeutics, Inc. has the higher net margin (0.00% vs −6.93%) and the higher return on invested capital (0.00% vs −5.64%). Across the 18 metrics below, Palvella Therapeutics, Inc. leads on 9 and Sarepta Therapeutics, Inc. on 9.
Valuation
Profitability
| Metric | PVLA | SRPT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 59.09% | 65.16% |
| Operating margin | 0.00% | (7.26%) | 0.00% |
| Net margin | 0.00% | (6.93%) | 0.00% |
| Free cash flow margin | 0.00% | 3.80% | 0.00% |
| Return on equity | (46.63%) | (9.48%) | (56.36%) |
| Return on assets | (37.70%) | (3.98%) | (48.04%) |
| Return on invested capital | 0.00% | (5.64%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack